Empery Asset Management »

Nervgen Pharma Ord shares owned by Empery Asset Management

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.2M 4.0M 2.06

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Marshall Wace
PFG Investments
Bank of America Corporation
Royal Bank of Canada
Integrated Wealth Concepts
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Axq Capital
Advisor Group Holdings
Commonwealth Equity Services
McKinley Carter Wealth Services
Cetera Investment Advisers
Patriot Financial Group Insurance Agency

View all funds holding Nervgen Pharma Ord